Literature DB >> 33420724

Sociodemographic and health-related determinants of seasonal influenza vaccination in pregnancy: A systematic review and meta-analysis of the evidence since 2000.

George N Okoli1,2,3, Viraj K Reddy2, Yahya Al-Yousif2, Christine J Neilson4, Salaheddin M Mahmud1,3,5, Ahmed M Abou-Setta2,5.   

Abstract

INTRODUCTION: Vaccination is considered to be the most practical and effective preventative measure against influenza. It is highly recommended for population subgroups most at risk of developing complications, including pregnant women. However, seasonal influenza vaccine uptake remains suboptimal among pregnant women, even in jurisdictions with universal vaccination. We summarized the evidence on the determinants of seasonal influenza vaccine uptake during pregnancy to better understand factors that influence vaccine uptake among pregnant women.
MATERIAL AND METHODS: We systematically searched MEDLINE, Embase and CINAHL from January 2000 to February 2020 for publications in English reporting on sociodemographic and/or health-related determinants of seasonal influenza vaccine uptake during pregnancy. Two reviewers independently included studies. One reviewer extracted data and assessed study quality, and another reviewer checked extracted data and study quality assessments for errors. Disagreements were resolved through consensus, or a third reviewer. We meta-analyzed using the inverse variance, random-effects method, and reported the odds ratios (OR) and 95% confidence intervals (CI).
RESULTS: From 1663 retrieved citations, we included 36 studies. The following factors were associated with increased seasonal influenza vaccine uptake: Older age (20 studies: OR 1.13, 95% CI 1.07-1.20), being nulliparous (13 studies: OR 1.26, 95% CI 1.15-1.38), married (8 studies: OR 1.11, 95% CI 1.07-1.15), employed (4 studies: OR 1.13, 95% CI 1.02-1.24), a non-smoker (8 studies: OR 1.25, 95% CI 1.04-1.51) and having prenatal care (3 studies: OR 3.36, 95% CI 2.25-5.02), a chronic condition (6 studies: OR 1.30, 95% CI 1.17-1.44), been previously vaccinated (9 studies: OR 4.88, 95% CI 3.14-7.57) and living in a rural area (9 studies: OR 1.09, 95% CI 1.05-1.14). Compared with being black, being white was also associated with increased seasonal influenza vaccine uptake (11 studies: OR 1.30, 95% CI 1.20-1.41).
CONCLUSIONS: The evidence suggests that several sociodemographic and health-related factors may determine seasonal influenza vaccination in pregnancy, and that parity, history of influenza vaccination, prenatal care and comorbidity status may be influential.
© 2021 Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  determinants; meta-analysis; pregnant women; seasonal influenza; seasonal influenza vaccine; systematic review; vaccination

Mesh:

Substances:

Year:  2021        PMID: 33420724     DOI: 10.1111/aogs.14079

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Trends of influenza vaccination coverage in pregnant women: a ten-year analysis from a French healthcare database.

Authors:  Mélodie Corbeau; Aurélien Mulliez; Chouki Chenaf; Bénédicte Eschalier; Olivier Lesens; Philippe Vorilhon
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

2.  Influenza and Pertussis Maternal Vaccination Coverage and Influencing Factors in Spain: A Study Based on Primary Care Records Registry.

Authors:  María Isabel Fernández-Cano; Antonia Arreciado Marañón; Azahara Reyes-Lacalle; Maria Feijoo-Cid; Josep Maria Manresa-Domínguez; Laura Montero-Pons; Rosa Maria Cabedo-Ferreiro; Pere Toran-Monserrat; Gemma Falguera-Puig
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

3.  Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study.

Authors:  M Lumbreras Areta; A Valiton; A Diana; M Morales; J Wiederrecht-Gasser; S Jacob; A Chilin; S Quarta; C Jaksic; J R Vallarta-Robledo; B Martinez de Tejada
Journal:  Vaccine       Date:  2022-05-06       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.